For media inquires, please email press@juul.com.
April 26, 2021
This month we celebrate a significant milestone in our efforts to expand the body of evidence surrounding vapor products with the publication of 11 peer-reviewed studies in a monograph edition of the American Journal of Health Behavior (AJHB).
April 9, 2021
Juul Labs Canada is committed to resetting the vaping products category in Canada – this means re-earning trust by working collaboratively with regulators, policymakers…
February 24, 2021
Juul Labs today announced findings from its science and research program at the 2021 Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT), which was held virtually.
February 18, 2021
An emerging public health issue, illicit vapor products undermine underage-prevention measures and may present additional health and safety risks for adult consumers.
February 11, 2021
As we continue to do our part to support enforcement against black-market vapor products in the United States and abroad, Juul Labs is pleased to announce the disruption of another illicit enterprise involved in the manufacture and international distribution of counterfeit JUUL products in China.
January 25, 2021
A separate study of JUUL purchasers found higher rates of complete transitioning away from cigarettes among adult smokers in the US and Canada than in the United Kingdom, where the JUUL System is only available in lower concentrations of nicotine.
January 19, 2021
Juul Labs is proud to announce that the National Crime Prevention Council (NCPC) and National Intellectual Property Rights Coordination Center (IPRC) have released an…
December 15, 2020
We are encouraged that according to the paper in JAMA Pediatrics underage use of JUUL products, “dropped dramatically,” which shows the importance of evidence-based…
November 11, 2020
A clinical study recently published in the journal Drug and Alcohol Dependence compared the nicotine delivery profile of the JUUL System with other nicotine-containing products, including cigarettes, in order to assess their pharmacokinetic or “PK” profiles
November 6, 2020
Juul Labs Chief Regulatory Officer Joe Murillo recently participated in a panel discussion at the 2020 Food & Drug Law Institute (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference, where he discussed the role of nicotine in tobacco harm reduction.